Small molecule SIRT1 activators for the treatment of aging and age-related diseases
Top Cited Papers
- 19 January 2014
- journal article
- review article
- Published by Elsevier BV in Trends in Pharmacological Sciences
- Vol. 35 (3), 146-154
- https://doi.org/10.1016/j.tips.2013.12.004
Abstract
No abstract availableKeywords
This publication has 105 references indexed in Scilit:
- SIRT1 Is Required for AMPK Activation and the Beneficial Effects of Resveratrol on Mitochondrial FunctionCell Metabolism, 2012
- Resveratrol has antiinflammatory and antifibrotic effects in the peptidoglycan-polysaccharide rat model of Crohnʼs diseaseInflammatory Bowel Diseases, 2012
- Resveratrol Ameliorates Aging-Related Metabolic Phenotypes by Inhibiting cAMP PhosphodiesterasesCell, 2012
- Resveratrol induces p53 and suppresses myocardin-mediated vascular smooth muscle cell differentiationToxicology Letters, 2010
- Novel Cambinol Analogs as Sirtuin Inhibitors: Synthesis, Biological Evaluation, and Rationalization of ActivityJournal of Medicinal Chemistry, 2009
- Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's diseaseNeurochemistry International, 2008
- Resveratrol Delays Age-Related Deterioration and Mimics Transcriptional Aspects of Dietary Restriction without Extending Life SpanCell Metabolism, 2008
- Resveratrol improves health and survival of mice on a high-calorie dietNature, 2006
- Sirtuin activators mimic caloric restriction and delay ageing in metazoansNature, 2004
- Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespanNature, 2003